Advertisement

HindustanTimes Sat,30 Aug 2014

GDP growth may go up to 5.5% in FY15: Icra

PTI  Mumbai, May 28, 2014
First Published: 15:43 IST(28/5/2014) | Last Updated: 15:50 IST(28/5/2014)

Domestic ratings agency Icra on Wednesday said GDP growth in 2014-15 may touch 5.5% as pick up in manufacturing and investment is expected in the second half of the current fiscal.

"Indian GDP growth has bottomed out in first half of 2014, and we expect a mild improvement in the pace of growth from 4.6% in 2013-14 to 5-5.5% in 2014-15," Icra said in a note.

A "muted" pickup in the sagging manufacturing growth and investment activity in the second half of the fiscal will make it possible for the overall GDP growth to move up, it added.

Listing out priorities for the Finance Ministry under Arun Jaitley and the Narendra Modi government as a whole, it said the growth rate can pick up to 6% with the extent and pace of reform measures.

GDP growth in FY13 slipped to 4.5% on account of a slew of issues including a perceived 'policy paralysis' under the then government, slowdown in the global markets, high interest rates and a slowdown in investments.
It is widely expected to climb up from that number in FY14, with the government's official estimate coming at around 4.8%.

A consistent roadmap on fiscal consolidation, with clarity on issues like tax reforms, disinvestment and expenditure rationalisation, is the top priority listed out by the agency.

It said that reviving growth and containing inflation should be the core concern of the government, and called for a "balanced approach" to the farm sector which will ensure food security as well as help contain price rise.

Other points suggested by the agency include clearing the projects stuck for want of approvals which will help kickstart investments and also measures to simplify business and taxation rules.

Icra called for creating consensus with the state governments for the early introduction of the Goods and Services Tax, and also reforms in the APMC (Agricultural Produce Marketing Committee) Acts.


Advertisement
more from Business

Sun-Ranbaxy deal: CCI raises concerns about molecules mkt

The Competition Commission, which has put the multi-billion dollar Sun-Ranbaxy deal for public scrutiny, said on Friday the major issue is whether the combination would result in high market concentration of certain molecules.

markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved